Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.
1. Chapter 2 : Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation - p. Page 13 2. Chapter 3 : Deprescribing is an essential part of prescribing - p. Page 44 3. Chapter 4 : Deprescribing in school curriculums: An overview of current education standards and what should be changed - p. Page 66 4. Chapter 5 : The role of the multidisciplinary healthcare team in deprescribing - p. Page 86 5. Chapter 6 : Looking to the future: Artificial intelligence in enhancing patient care* - p. Page 102 6. Chapter 7 : Challenges/barriers of deprescribing during COVID-19 - p. Page 119 7. Chapter 8 : Deprescribing in palliative care and Alzheimer’s patients: Optimizing medication use for improved quality of life - p. Page 135 8. Index - p. Page 148
Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population.
1. Chapter 2 : Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation - p. Page 13 2. Chapter 3 : Deprescribing is an essential part of prescribing - p. Page 44 3. Chapter 4 : Deprescribing in school curriculums: An overview of current education standards and what should be changed - p. Page 66 4. Chapter 5 : The role of the multidisciplinary healthcare team in deprescribing - p. Page 86 5. Chapter 6 : Looking to the future: Artificial intelligence in enhancing patient care* - p. Page 102 6. Chapter 7 : Challenges/barriers of deprescribing during COVID-19 - p. Page 119 7. Chapter 8 : Deprescribing in palliative care and Alzheimer’s patients: Optimizing medication use for improved quality of life - p. Page 135 8. Index - p. Page 148
